UPDATE: William Blair Starts Lifestance Health Group (LFST) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Morgan Stanley Starts Lifestance Health Group (LFST) at Overweight
July 6, 2021 12:52 AM EDTMorgan Stanley analyst Ricky Goldwasser initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.
The analyst comments "We apply a 11.5x EV/22revenue multiple to our base case 2023 $1.2b revenue estimate,a +1x turn... More
JPMorgan Starts Lifestance Health Group (LFST) at Overweight
July 6, 2021 12:50 AM EDTJPMorgan analyst Lisa Gill initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.
The analyst comments "The largest outpatient behavioral health platform in the U.S., LifeStance aims to disrupt the traditional model which suffers from: 1) low... More
UPDATE: Jefferies Starts Lifestance Health Group (LFST) at Buy
July 5, 2021 10:36 PM EDT(Updated - July 6, 2021 7:20 AM EDT)
Jefferies analyst Stephanie Wissink initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Buy rating and a price target of $36.00.
The analyst commented, "We are initiating coverage of LifeStance at Buy, backed by its leading... More
Goldman Sachs Starts Lifestance Health Group (LFST) at Neutral
July 5, 2021 10:34 PM EDTGoldman Sachs analyst Jamie Perse initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Neutral rating and a price target of $25.00.
The analyst comments "LifeStance is a leading provider of outpatient mental health services focused on reducing barriers to treatment. LFST... More
